Shenzhen Neptunus Bioengineering Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 28,640.39 million compared to CNY 28,955.75 million a year ago. Revenue was CNY 28,640.39 million compared to CNY 28,955.75 million a year ago.

Net income was CNY 88.48 million compared to CNY 131.91 million a year ago. Basic earnings per share from continuing operations was CNY 0.0322 compared to CNY 0.048 a year ago. Diluted earnings per share from continuing operations was CNY 0.0322 compared to CNY 0.048 a year ago.